Please use this identifier to cite or link to this item: 10.3390/medicina59071339
Title: Stability of Direct Oral Anticoagulants Concentrations in Blood Samples for Accessibility Expansion of Chromogenic Assays
Authors: Gavrilova, Anna
Meisters, Jānis
Latkovskis, Gustavs
Urtāne, Inga
Department of Pharmaceutical Chemistry
Red Cross Medical College of Rīga Stradiņš University
Keywords: Humans;Dabigatran/therapeutic use;Rivaroxaban/therapeutic use;Pyridines/therapeutic use;Citric Acid;Citrates;Anticoagulants/pharmacology;3.1 Basic medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database
Issue Date: 21-Jul-2023
Citation: Gavrilova , A , Meisters , J , Latkovskis , G & Urtāne , I 2023 , ' Stability of Direct Oral Anticoagulants Concentrations in Blood Samples for Accessibility Expansion of Chromogenic Assays ' , Medicina (Kaunas, Lithuania) , vol. 59 , no. 7 , 1339 . https://doi.org/10.3390/medicina59071339
Abstract: Background and Objectives: Direct oral anticoagulants (DOACs) are used for minimising the risk of thromboembolic events. In clinical practice, there is no need to measure DOAC concentration in the routine. Nevertheless, there are cases where such measurements are necessary, as the European Society of Cardiology's guideline recommends. However, determining DOAC levels is not available for everyone due to chromogenic assay availability limitations from sample storage problems, as tests are performed only in a few healthcare settings. This study aimed to assess whether more applicable storage conditions could be used for transportation to provide chromogenic assays for outpatient healthcare and other hospitals' practices. Materials and Methods: Chromogenic assays measuring anti-FXa (for rivaroxaban and edoxaban) and anti-FIIa (for dabigatran) were used. Concentrations were determined immediately after blood collection as baseline value: (1) after the storage of citrated whole blood in refrigerator (+2-8 °C); (2) of citrated plasma in refrigerator (+2-8 °C); and (3) of citrated frozen plasma (-20 °C) on the third and seventh days of storage. Acceptable change limits were considered stable if the deviation did not exceed ±20% of the baseline value. Results: The median (Cl 95%) baseline value of rivaroxaban was 168 (147-236) ng/mL; of dabigatran 139 (99-178) ng/mL; and of edoxaban-174 (135-259) ng/mL. The median deviation from a baseline value stored as citrate whole blood samples (+2-8 °C) was 5.4% and 3.4%; as citrated plasma (+2-8 °C) was 0.4% and -0.6%; and as citrated frozen plasma (-20 °C) was -0.2% and 0.2% on the third and seventh days of storage, respectively. Conclusions: Our data suggest that whole blood samples stored in a refrigerator, as well as citrated plasma samples stored in both the refrigerator and freezer, preserve DOAC concentration stable at +2-8 °C or -20 °C for up to 7 days, and are suitable for transportation, except for low-concentration samples.
Description: Publisher Copyright: © 2023 by the authors.
DOI: 10.3390/medicina59071339
ISSN: 1010-660X
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
medicina-59-01339-v2.pdf2.19 MBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.